Insider sales are immaterial in size and likely liquidity-driven (CFO exercised options and sold a portion to cover taxes). No bearish signal. Monitor for any material insider purchases or larger sales (>$5M) that would indicate a change in sentiment.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 4 $78.48entry
- T+1 · 6mo ago −6.15%α −3.56% · $73.65
- T+5 · 5mo ago +2.92%α +5.47% · $80.77
- T+20 · 4mo ago +10.38%α +11.76% · $86.63
- T+60 · 3mo ago +15.14%α +13.26% · $90.36
Price Chart
How similar events traded
Executive Summary
CEO Turtle Cameron and CFO Scott Burrows sold a combined $372K in SYRE stock on June 1, 2026, at ~$69.40-$69.75. The CFO also exercised options for $108,750 and had shares withheld for taxes (non-cash). At a $6.4B market cap, the sales represent ~0.006% of market cap, trivial in size and consistent with routine portfolio diversification or tax planning. The cluster is not informative given the small dollar amounts and the CFO's concurrent option exercise.
Key Financial Metrics
Key Facts
- CEO sold 3,557 shares for $247K at $69.40
- CFO sold 1,801 shares for $126K at $69.75
- CFO exercised 7,500 options at $14.50 for $108,750 (non-cash exercise)
- Total open-market sales: $372K, representing ~0.006% of $6.4B market cap
- No insider purchases in the cluster
Financial Impact
Total insider sales of $372K are negligible relative to $6.4B market cap (0.006%). CFO's option exercise is a non-cash event with no economic impact.
Risk Factors
- Insider sales, while small, could precede negative news if they accelerate in size or frequency
- CFO's option exercise adds 7,500 shares to the float, but the net dilution is negligible
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1780536706609 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers